D-TAGATOSE COMPOSITIONS AND METHODS OF PREVENTING AND TREATING ATHEROSCLEROSIS, METABOLIC SYNDROME AND SYMPTOMS THEREOF Russian patent published in 2013 - IPC A61K31/7004 A61K47/26 A61K45/00 A61K31/65 A61P9/10 A61P1/04 A61P3/04 A23L1/30 

Abstract RU 2484827 C2

FIELD: medicine, pharmaceutics.

SUBSTANCE: there are offered: a pharmaceutical composition for preventing or treating atherosclerosis, metabolic syndrome, diabetes, obesity or their symptoms, or the combinations thereof, containing a pharmaceutically effective amount of D-tagatose or a salt, sugar alcohol, hydrate, solvate, ester or amide thereof, and a pharmaceutically effective amount of a second pharmaceutically active agent containing stilbene or a stilbenoid component or any salt, alcohol, hydrate, ester, amide, polymorph, isomer thereof, or a combination thereof, a related method of treating or preventing these diseases, the use of said composition for preparing a medicine or vaccine for the same application and a food stuff containing a pharmaceutically effective amount of D-tagatose or a salt, sugar alcohol, hydrate, solvate, ester or amide thereof, and a pharmaceutically effective amount of a second pharmaceutically active agent containing stilbene or a stilbenoid component or a salt, alcohol, hydrate, ester, amide, polymorph, isomer thereof, or a combination thereof.

EFFECT: declared combination reduces blood plasma triglyceride, including in additional carbon diet.

30 cl, 3 ex

Similar patents RU2484827C2

Title Year Author Number
COMBINATIONS AND COMPOSITIONS CONTAINING FATTY ACIDS AND AMINO ACIDS, THEIR APPLICATION FOR PREVENTION AND DELAY OF PROGRESSING OR TREATMENT OF DIABETES AND DIABETES ASSOCIATED DISEASES AND CONDITIONS, METHOD OF WEIGHT REDUCTION IN MAMMAL, KIT 2004
  • Troup Dzhon P.
  • Ber Mikhaehl'
RU2356247C2
METHODS AND COMPOSITIONS FOR TREATING OBESITY, PREVENTING MASS INCREASE, PROMOTING MASS REDUCTION, PROMOTING WEIGHT LOSS OR TREATING OR PREVENTING DIABETES FROM DEVELOPING 2015
  • Gojon-Zorrilla, Gabriel
  • Gojon-Romanillos, Gabriel
RU2745440C2
USE OF A COMPOSITION CONSISTING OF THE AMINO ACIDS GLYCINE, ARGININE, CYSTEINE AND RESVERATROL TO REDUCE THE SEVERITY OF DIABETES AND HIGH CONTENT OF FAT, CHOLESTEROL, URIC ACID, BLOOD GLUCOSE AND ACCELERATED AGING IN ANIMALS AND HUMANS 2017
  • Astudillo De La Vega, Horacio
RU2749950C2
DOCOSAHEXAENOIC ACID DERIVATIVES AND THEIR APPLICATION AS DRUGS 2006
  • Brin Morten
  • Kholmejd Ehnn Kristen
  • Kopetski Jan
RU2441061C2
FOOD PRODUCT FOR DIABETICS 2005
  • Shul'Man Avidor
  • Pelled Dori
  • Kouehn Tsafra
RU2380983C2
FGF21 Fc FUNCTION PROTEIN, GLP-1 Fc FUNCTION PROTEIN AND COMBINED THERAPEUTIC AGENT INCLUDING THEM AND THEIR USE 2020
  • Dun, Chzhao
  • Chzhou, Chi
  • Chzhan, Tsziyu
  • Li, Yuanli
  • Li, Tsyan
RU2804335C2
METHOD OF IMPROVEMENT OF LIVER FUNCTION 2013
  • Uolder Ken
  • Krippner Gaj
  • Nikolson Dzhoff
RU2653478C2
ACYLATED GLUCAGON ANALOGUE, USE THEREOF AND METHODS OF PRODUCING 2016
  • Riber, Ditte
  • Tolborg, Yakob Lind
  • Khamprekht, Diter Volfgang
  • Tomas, Leo
RU2735762C2
COMPOSITION CONTAINING COMBINATION OF AT LEAST ONE PROTEOLYTIC ENZYME AND AT LEAST ONE LIPOLYTIC ENZYME USED TO PREVENT TRIGLYCERIDE SYNTHESIS 2011
  • Rombi Maks
RU2536295C2
COMPOUNDS FOR METABOLIC DISORDER TREATMENT 2004
  • Sharma Shalini
  • Von Borstel Rejd V.
  • Khodzh Kirvin L.
RU2349584C2

RU 2 484 827 C2

Authors

Lodder Robert A.

Kassis Liza A.

Dates

2013-06-20Published

2009-11-04Filed